Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Hormones
Published in: Hormones 4/2013

01-10-2013 | Research paper

Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome

Authors: Ekaterini Koiou, Konstantinos Tziomalos, MD, PhD, Ilias Katsikis, Dimitrios Delkos, Elena A. Tsourdi, Dimitrios Panidis

Published in: Hormones | Issue 4/2013

Login to get access
Metadata
Title
Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome
Authors
Ekaterini Koiou
Konstantinos Tziomalos, MD, PhD
Ilias Katsikis
Dimitrios Delkos
Elena A. Tsourdi
Dimitrios Panidis
Publication date
01-10-2013
Publisher
Springer International Publishing
Published in
Hormones / Issue 4/2013
Print ISSN: 1109-3099
Electronic ISSN: 2520-8721
DOI
https://doi.org/10.14310/horm.2002.1444

Other articles of this Issue 4/2013

Hormones 4/2013 Go to the issue

Mini review

The validity of current guidelines regarding surgical management of patients with gastric neuroendocrine neoplasms type 1: a report of a series of seven patients

Letter to the Editor

Comment on A. Ghemigian, et al Familial isolated primary hyperparathyroidism due to HRPT2 mutation

Research paper

Ten-Year obesity and overweight prevalence in Greek children: A systematic review and meta-analysis of 2001–2010 data

Review

A review of the metabolic effects of controlled-release Phentermine/Topiramate

Research paper

Thyroglossal duct cyst carcinomas: is there a need for thyroidectomy?

Review

Oral glucose lowering drugs in type 2 diabetic patients with chronic kidney disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits